Literature DB >> 1743286

An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase.

M Arand1, M Knehr, H Thomas, H D Zeller, F Oesch.   

Abstract

To gain an understanding of the mechanism by which the subcellular distribution of cytosolic epoxide hydrolase (cEH) is directed, we have analyzed the carboxy terminal region of rat liver cEH by means of cDNA cloning to define the structure of its possible peroxisomal targeting sequence (PTS). Purified cEH was subjected to peptide analysis following endoproteinase Glu-C digestion and HPLC-separation of the fragments. The obtained sequence information was used to perform PCR experiments resulting in the isolation of a 680 bp cDNA clone encoding the carboxy terminus of cEH. The deduced amino acid sequence displays a terminal tripeptide Ser-Lys-Ile which is highly homologous to the PTS (Ser-Lys-Leu) found in other peroxisomal enzymes. This slight difference appears to be sufficient to convert the signal sequence into an impaired and therefore ambivalent PTS, directing the enzyme partly to the peroxisomes and allowing part to reside in the cytosol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743286     DOI: 10.1016/0014-5793(91)81333-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

Authors:  M A Argiriadi; C Morisseau; B D Hammock; D W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Two birds with one stone: genes that encode products targeted to two or more compartments.

Authors:  I Small; H Wintz; K Akashi; H Mireau
Journal:  Plant Mol Biol       Date:  1998-09       Impact factor: 4.076

3.  Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12.

Authors:  C Larsson; I White; C Johansson; A Stark; J Meijer
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

4.  Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase.

Authors:  Annette Cronin; Martina Decker; Michael Arand
Journal:  J Lipid Res       Date:  2011-01-07       Impact factor: 5.922

5.  Tissue specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the mRNA levels in extrahepatic tissues and liver.

Authors:  C Johansson; A Stark; M Sandberg; B Ek; L Rask; J Meijer
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  The peroxisomal targeting sequence type 1 receptor, Pex5p, and the peroxisomal import efficiency of alanine:glyoxylate aminotransferase.

Authors:  T G Knott; G M Birdsey; K E Sinclair; I M Gallagher; P E Purdue; C J Danpure
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

Review 7.  Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Authors:  Bora Inceoglu; Kara R Schmelzer; Christophe Morisseau; Steve L Jinks; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-07-05       Impact factor: 3.072

8.  Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase.

Authors:  Beibei Luo; Carol Norris; Erin S D Bolstad; David A Knecht; David F Grant
Journal:  J Mol Biol       Date:  2008-05-03       Impact factor: 5.469

9.  Silencing of soluble epoxide hydrolase 2 gene reduces H2O2-induced oxidative damage in rat intestinal epithelial IEC-6 cells via activating PI3K/Akt/GSK3β signaling pathway.

Authors:  Jun Li; Jihui Luo; Yang Zhang; Chunming Tang; Jiang Wang; Chaowu Chen
Journal:  Cytotechnology       Date:  2020-01-06       Impact factor: 2.058

Review 10.  Redox interplay between mitochondria and peroxisomes.

Authors:  Celien Lismont; Marcus Nordgren; Paul P Van Veldhoven; Marc Fransen
Journal:  Front Cell Dev Biol       Date:  2015-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.